Pharming Group reports financial results for the first nine months of 2020

October 29, 2020 at 12:00 AM EDT

Pharming Group N.V. presents its (unaudited) financial report for the nine months and third quarter ended 30 September 2020.

Highlights:

Continued solid performance and strong recovery of sales in Q3 2020
Delivered 9.2% increase in revenues, 19.8% increase in operating profit and 6.4% increase in net profit (59% increase on constant currency basis) year-on-year for the first nine months of 2020
Company has initiated the process for a secondary listing in the US on Nasdaq